FHIT+/− mice are, however, much more prone to develop tumors in response to carcinogen treatment (Fong et al., 2000; Zanesi et al., 2001), and both FHIT+/− and FHIT−/− mice have a higher frequency of spontaneous tumor development (Zanesi et al., 2001). Here, FHIT is linked to neoplasm.